Ciphergen forms blood disorder test deal
This article was originally published in Clinica
Ciphergen Biosystems and Ohio State University Research Foundation (OSURF) in the US have teamed up to develop and clinically validate a test for the haematologic disease, thrombotic thrombocytopoenic purpura (TTP).
You may also be interested in...
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.
At the OurCrowd Global Investor Summit, in Jerusalem, Israel, on 13 February, Medtech Insight met with start-up Sweetch, which has developed a personalized digital health coach for wellness and disease management.
Medtech Insight attended the OurCrowd Global Investor Summit in Jerusalem on February 13. At the meeting, Ofer Barnea, CEO of neurosurgery start-up SynCath Neuroscience, explained his company’s device to treat cerebral edema,